Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study
{{output}}
Background: Emerging data suggest a substantial risk of arterial and venous thromboembolic events (ATE/VTE) associated with targeted cancer therapies. We examined the association between selected targeted therapies and ATE/VTE-ri... ...
